Antibiotics and antipsychotics: ciprofloxacin, erythromycin, and QT

Antibiotics get prescribed in moments of pressure — a urinary infection, pneumonia, a wound infection — and the conversation about drug interactions is often brief. For people on antipsychotics, several common antibiotic classes interact in ways that are worth knowing about. Sometimes the interaction is at the level of liver enzymes (changing antipsychotic blood levels). Sometimes it is at the level of cardiac conduction (additive QT prolongation). Sometimes both.

The two main mechanisms

Liver enzyme inhibition

The cytochrome P450 enzymes in the liver process most antipsychotics. The main ones for antipsychotics are CYP1A2 (clozapine, olanzapine), CYP3A4 (quetiapine, lurasidone, aripiprazole partially), and CYP2D6 (risperidone, aripiprazole, haloperidol). Some antibiotics inhibit these enzymes — meaning they slow down the breakdown of the antipsychotic and raise its blood level.

QT prolongation

Many antipsychotics modestly prolong the QT interval on the ECG. Several antibiotics do the same. When the two stack, the risk of a dangerous heart rhythm called torsades de pointes (TdP) goes up, especially in older patients, those with heart disease, electrolyte disturbances (low potassium or magnesium), or other QT-prolonging drugs. A separate article covers QT prolongation in detail.

Class by class

Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin)

Ciprofloxacin is a strong CYP1A2 inhibitor. In clozapine users, ciprofloxacin can raise clozapine levels two- to threefold within days. Case reports describe sedation, hypotension, and seizures. The effect on olanzapine is similar but usually clinically less dramatic. Levofloxacin has less CYP1A2 effect. Moxifloxacin is the fluoroquinolone with the most QT prolongation and is generally avoided in patients on QT-prolonging antipsychotics. The FDA has issued multiple safety warnings on fluoroquinolones in recent years for tendinitis, peripheral neuropathy, and aortic aneurysm risk; their use is increasingly restricted to situations where alternatives are not appropriate.

Macrolides (erythromycin, clarithromycin, azithromycin)

Erythromycin and clarithromycin are strong CYP3A4 inhibitors and prolong the QT interval. They can raise levels of quetiapine, lurasidone, and partially aripiprazole. Azithromycin has minimal CYP3A4 effect but does carry a smaller QT signal — the FDA issued a safety communication in 2013 about azithromycin and cardiac risk. For patients on QT-sensitive antipsychotics, doxycycline or another non-QT antibiotic is often preferred.

Penicillins, cephalosporins, doxycycline

Most of these have negligible interactions with antipsychotics. Amoxicillin, cephalexin, and doxycycline are usually safe choices in patients on antipsychotics — which is part of why they remain first-line for many infections.

Trimethoprim-sulfamethoxazole (Bactrim, Septra)

Inhibits CYP2C9 modestly and can affect bone marrow. In clozapine users (who are already on weekly or monthly blood monitoring), this drug can confound interpretation of the white cell count. Combining bone marrow-suppressive drugs with clozapine is not absolutely contraindicated but needs close monitoring.

Linezolid

Linezolid has weak monoamine oxidase inhibitor activity. It is generally cautioned against in patients on serotonergic medications because of serotonin syndrome risk, and warrants prescriber discussion in patients on multiple psychotropics.

Rifampin (rifampicin)

The opposite problem: rifampin is a powerful inducer of CYP3A4 and other enzymes. It can dramatically lower antipsychotic blood levels. Quetiapine levels can drop by 80% or more. Patients on rifampin (most often for tuberculosis or some serious infections) may need temporary dose adjustments.

Antifungals (fluconazole, itraconazole, ketoconazole, voriconazole)

Strong CYP3A4 inhibitors. Itraconazole and ketoconazole in particular can substantially raise levels of CYP3A4-metabolised antipsychotics. Lurasidone is essentially contraindicated with strong CYP3A4 inhibitors (per the FDA label). Quetiapine levels can also rise significantly.

Practical principles

1. Tell the antibiotic-prescribing clinician what antipsychotic you are on, including the dose. Pharmacies catch many interactions but not all.
2. If a fluoroquinolone is being prescribed for a clozapine user, ask whether levofloxacin (less CYP1A2 effect) or a non-fluoroquinolone alternative is appropriate.
3. If a macrolide is being prescribed for someone on a QT-sensitive antipsychotic (ziprasidone, iloperidone, IV haloperidol), ask whether azithromycin (lower interaction) or doxycycline is suitable.
4. For patients on lurasidone or quetiapine, avoid strong CYP3A4 inhibitors when possible.
5. Symptom monitoring during a course of interacting antibiotics matters — increased sedation, dizziness, palpitations, or any new symptoms should be reported.

The infection itself

Infections — particularly with fever and dehydration — independently raise the risk of side effects from many antipsychotics. Clozapine in particular sees plasma levels rise during acute illness because inflammation reduces CYP1A2 activity. This effect is real and can be dramatic, sometimes more so than the antibiotic interaction itself.

Talking to your team

Carry a list of your medications, including doses, on your phone. Show it to any clinician who is starting a new prescription. The single most useful thing patients can do is make sure the new prescriber actually knows what is already in the picture.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.